For in vitro diagnostic use.

The presence of CTCs in the peripheral blood, as detected by the CELLSEARCH® CTC Test, is associated with decreased progression-free survival and decreased overall survival in patients treated for metastatic breast, colorectal, or prostate* cancer. The test is to be used as an aid in the monitoring of patients with metastatic breast, colorectal, or prostate cancer. Serial CTC testing should be used in conjunction with other clinical methods for monitoring metastatic breast, colorectal, and prostate* cancer. Evaluation of CTCs at any time during the course of disease allows assessment of patient prognosis and is predictive of progression-free survival and overall survival.

CELLSEARCH® CTC Test results should be used in conjunction with all clinical information derived from diagnostic tests (eg, imaging, laboratory tests), physical examination, and complete medical history, in accordance with appropriate management procedures.

For in vitro diagnostic use.

The presence of CTCs in the peripheral blood, as detected by the CELLSEARCH® CTC Test, is associated with decreased progression free survival and decreased overall survival in patients treated for metastatic breast, colorectal, or prostate* cancer. The test is to be used as an aid in the monitoring of patients with metastatic breast, colorectal, or prostate cancer. Serial CTC testing should be used in conjunction with other clinical methods for monitoring

CELLSEARCH® CTC Test results should be used in conjunction with all clinical information derived from diagnostic tests (eg, imaging, laboratory tests), physical examination, and complete medical history, in accordance with appropriate management procedures.

*Metastatic prostate cancer patients were defined as having two consecutive increases in the serum marker prostate-specific antigen above a reference level, despite standard hormonal management. These patients are commonly described as having androgen-independent, hormone-resistant, or castration-resistant prostate cancer. For more information on the intended use and limitations for the CELLSEARCH® Circulating Tumor Cell Test, please refer to the Instructions for Use which can be found at documents.cellsearchctc.com.

Signup for Updates

First Name

Last Name

Your Email *

Confirm *

I would like to receive email updates about CELLSEARCH®

I would like to receive email updates about Janssen Diagnostics, LLC

By submitting this form, you are agreeing that we may email you with additional information about CELLSEARCH® and/or Janssen Diagnostics, LLC. This information will not be used for any other purposes other than to send you the communications you requested. For more information, see our Privacy Policy. From any email we send, you will have the opportunity to opt-out of receiving future emails.

Email This Page

Your Name *

Your Email *

To Email *

By submitting an email address, you are requesting that we contact on your behalf the person you specify here. Your name and contact information and the recipient's contact information are required, however, this contact information will not be used for any other purposes other than to distribute the communication you request. For more information, see our Privacy Policy.